---
figid: PMC9409235__ijms-23-09196-g002
figtitle: 'mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease'
organisms:
- Escherichia coli
- Streptococcus sp. group A
- Escherichia coli 53A
- Escherichia coli SCD1
- Streptomyces rapamycinicus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Candida dubliniensis
- gut metagenome
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC9409235
filename: ijms-23-09196-g002.jpg
figlink: /pmc/articles/PMC9409235/figure/ijms-23-09196-f002/
number: F2
caption: mTOR affects NAFLD through lipid metabolism (SREBPs), insulin resistance
  (Lipin1, Foxo1), and oxidative stress (PIG3, p53, JNK). (a). Excessive amounts of
  triglycerides stored in fat enter the liver as FFAs. Excessive triglyceride levels
  activate the feedback regulation of mTORC1 to block FFA-induced mitochondrial OS
  and the PIG3-p53-JNK-OS recycling pathway in the liver. mTORC1 can also regulate
  the effects of OS, mediated by NF-κB and PTEN. (b). FFAs activate Lipin1 and Foxo1
  through mTORC1, thereby affecting DAG and PKC levels to influence hepatic IR. (c).
  mTORC1 can regulate SREBP-1 and SREBP-2 levels after activation by CRTC2 and can
  phosphorylate Lipin1, which affects insulin levels. Furthermore, mTORC1 can indirectly
  affect DNL-related gene levels by directly regulating the nSREBP gene via Akt. mTORC1
  also directly suppresses DNL-related genes and thus exhibits feedback regulation
  of triglyceride synthesis. mTOR can affect triglyceride synthesis, liver lipid accumulation,
  liver gluconeogenesis, hepatitis, and fibrosis via the above three processes in
  NAFLD.
papertitle: 'mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease.'
reftext: Jiayao Feng, et al. Int J Mol Sci. 2022 Aug;23(16):9196.
year: '2022'
doi: 10.3390/ijms23169196
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: mTOR | nonalcoholic fatty liver disease | targeted therapy | notch | hedgehog
  | hippo
automl_pathway: 0.9323977
figid_alias: PMC9409235__F2
figtype: Figure
redirect_from: /figures/PMC9409235__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9409235__ijms-23-09196-g002.html
  '@type': Dataset
  description: mTOR affects NAFLD through lipid metabolism (SREBPs), insulin resistance
    (Lipin1, Foxo1), and oxidative stress (PIG3, p53, JNK). (a). Excessive amounts
    of triglycerides stored in fat enter the liver as FFAs. Excessive triglyceride
    levels activate the feedback regulation of mTORC1 to block FFA-induced mitochondrial
    OS and the PIG3-p53-JNK-OS recycling pathway in the liver. mTORC1 can also regulate
    the effects of OS, mediated by NF-κB and PTEN. (b). FFAs activate Lipin1 and Foxo1
    through mTORC1, thereby affecting DAG and PKC levels to influence hepatic IR.
    (c). mTORC1 can regulate SREBP-1 and SREBP-2 levels after activation by CRTC2
    and can phosphorylate Lipin1, which affects insulin levels. Furthermore, mTORC1
    can indirectly affect DNL-related gene levels by directly regulating the nSREBP
    gene via Akt. mTORC1 also directly suppresses DNL-related genes and thus exhibits
    feedback regulation of triglyceride synthesis. mTOR can affect triglyceride synthesis,
    liver lipid accumulation, liver gluconeogenesis, hepatitis, and fibrosis via the
    above three processes in NAFLD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tg
  - Wdtc1
  - Mapk8
  - Tas2r145-ps3
  - Creb1
  - Sting1
  - Prkce
  - Irs1
  - Pik3r1
  - Akt1
  - Foxo1
  - Dnmt3a
  - Lpin1
  - Pten
  - Nfkb1
  - Crtc2
  - H20
  - Decr1
  - Srebf1
  - Sqle
  - Scd1
  - Acc
  - Fasn
  - Srebf2
  - Trp53
  - Tfe3
  - Scap
  - Sorbs1
  - Lnpep
  - Flcn
  - TG
  - DNASE2
  - TP53I3
  - MRPL41
  - MAPK8
  - MAPK9
  - MAPK10
  - TAS2R6P
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - STING1
  - PRKCE
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - RPTOR
  - FOXO1
  - DNMT3A
  - PTEN
  - NFKB1
  - CRTC2
  - DECR1
  - SREBF1
  - SQLE
  - SCD
  - ACACA
  - BMS1
  - ACACB
  - FASN
  - SREBF2
  - TP53
  - TP63
  - TP73
  - TFE3
  - SCAP
  - SH2D2A
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - CAP1
  - SORBS1
  - BRD4
  - CAP2
  - FLCN
  - UBA2
  - Pik3cg
  - Scd
  - Tp53
  - Th
  - tg
  - mapk8b
  - irs1
  - foxo1a
  - ptenb
  - crtc2
  - scd
  - acaca
  - fasn
  - tp53
  - scap
  - flcn
  - Drl-2
  - bsk
  - scb
  - Crtc
  - CrebB
  - CrebA
  - Sting
  - aub
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - foxo
  - Dif
  - dl
  - Rel
  - SREBP
  - ACC
  - tacc
  - acclinal-wing
  - FASN1
  - FASN2
  - p53
  - betaTub60D
  - hth
  - bmm
  - CAP
  - SMC3
  - Cpn
  - Capa
  - capt
  - bel
  - SERCA
  - Cadps
---
